Detection of Hypoxia at the Cellular Level

Critical Care Clinics

Volumn 26, Issue 2, 2010, Pages 409-421

  Loiacono, Laurie A ^a,b   Shapiro, David S ^a,b  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers; Cytopathic hypoxia; Mitochondria; Multiple organ dysfunction syndrome; Sepsis; Tissue hypoxia

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 3; CASPASE 8; LACTIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; OXYGEN; PEROXYNITRITE; PYRUVATE DEHYDROGENASE; TUMOR NECROSIS FACTOR ALPHA;

CELL HYPOXIA; CELL LEVEL; CYTOPATHIC HYPOXIA; DYNAMICS; ENZYME ACTIVATION; HUMAN; HYPERDYNAMIC SEPSIS; HYPERLACTATEMIA; HYPODYNAMIC SEPSIS; KIDNEY PARENCHYMA; LACTIC ACIDOSIS; LIVER; LUNG ALVEOLUS WALL; LUNG PARENCHYMA; MITOCHONDRIAL RESPIRATION; MULTIPLE ORGAN FAILURE; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; SEPSIS; TISSUE OXYGENATION;

ACIDOSIS, LACTIC; BIOLOGICAL MARKERS; CELL HYPOXIA; HUMANS; MITOCHONDRIA; MULTIPLE ORGAN FAILURE; NITRIC OXIDE; OXYGEN CONSUMPTION; SEPSIS;

EID: 77951150286     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2009.12.001     Document Type: Review

References (65)

1. Connett R.J., Honig C.R., Gayeski E.J., et al. Defining hypoxia: a systems view of VO2, glycolysis, energetics, and intracellular PO2. J Appl Phys 1990, 68:833-842.
2. Duke T. Dysoxia and lactate. Arch Dis Child 1999, 81:343-350.
3. Hotchkiss R.S., Swanson P.E., Freeman B.D., et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999, 27:1230-1251.
4. Nunn J.F. Oxygen. Nunn's applied respiratory physiology 1993, 247-305. Butterworth-Heinemann Ltd, Oxford. J.F. Nunn (Ed.).
5. Guyton A.C. Transport of oxygen and carbon dioxide in the blood and body fluids. Textbook of medical physiology 1976, 543-571. WB Saunders, Philadelphia. 5th edition.
6. 2 in heart and skeletal muscle. Physiologist 1971, 14:69-82.
7. Kessler M.H., Lang H., Sinagowitz R., et al. Homeostasis of oxygen supply in liver and kidney. Oxygen transport to tissue. Instrumentation, methods and physiology. Advances in experimental medicine and biology 1973, vol. 37A:351-360. Plenum Press, New York. H.I. Bicher, D.F. Bruely (Eds.).
8. Chance B., Oshino N., Sugano T., et al. Basic principles of tissue oxygenation determination from mitochondrial signals. Oxygen transport to tissue. Instrumentation, methods and physiology. Advances in experimental medicine and biology 1973, vol. 37A:277-292. Plenum Press, New York. H.I. Bicher, D.F. Bruely (Eds.).
9. Treciak S., Dellinger R.P., Abate N.L., et al. Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest 2006, 129:225-232.
10. Boulos M., Astiz M.E., Barua R.S., et al. Impaired mitochondrial function induced by serum from septic shock patients is attenuated by inhibition of nitric oxide synthase and poly (ADP-ribose) synthase. Crit Care Med 2003, 31:353-358.
11. Rivers E.P., Kruse J.A., Jacobson G., et al. The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med 2007, 35(9):2016-2024.
12. Fink M. Cytopathic hypoxia in sepsis. Acta Anaesthesiol Scand Suppl 1997, 110:87-95.
13. Fink M.P. Cytopathic hypoxia. A concept to explain organ dysfunction in sepsis. Minerva Anestesiol 2000, 66(5):337-342.
14. Fink M.P. Cytopathic hypoxia in sepsis: a true problem?. Minerva Anestesiol 2001, 67(4):290-291.
15. Fink M. Cytopathic hypoxia. Is oxygen use impaired in sepsis as a result of an acquired intrinsic derangement in cellular respiration?. Crit Care Clin 2002, 18(1):165-175.
16. Fink M.P. Research: advances in cell biology relevant to critical illness. Curr Opin Crit Care 2004, 10:279-291.
17. Fink M.P. Administration of exogenous cytochrome c as a novel approach for the treatment of cytopathic hypoxia. Crit Care Med 2007, 35(9):2224-2225.
18. Gogos C.A., Drosou E., Bassaris H.P., et al. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000, 181:176-180.
19. Osuchowski M.F., Welch K., Siddiqui J., et al. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 2006, 177:1967-1974.
20. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
21. Fink M.P. Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin 2001, 17(1):219-237.
22. Vary T.C. Sepsis-induced alterations in pyruvate dehydrogenase complex activity in rat skeletal muscle: effects on plasma lactate. Shock 1996, 8:89.
23. Vary T.C., Hazen S. Sepsis alters pyruvate dehydrogenase kinase activity in skeletal muscle. Mol Cell Biochem 1999, 198:113.
24. Borutaite V., Brown G.C. Rapid reduction of nitric oxide by mitochondria, and reversible inhibition of mitochondrial respiration by nitric oxide. Biochem J 1996, 315:295.
25. Cassina A., Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 1996, 328:309.
26. Piel D.A., Gruber P.J., Weinheimer C.J., et al. Mitochondrial resuscitation with exogenous cytochrome c in the septic heart. Crit Care Med 2007, 35:2120-2127.
27. Gladden L.B. Lactate metabolism - a new paradigm for the third millennium. J Physiol 2004, 558:5-30.
28. Brooks G.A. Intra- and extra-cellular lactate shuttles. Med Sci Sports Exerc 2000, 32(4):790-800.
29. Cohen R.D., Woods H.F. Clinical and biochemical aspects of lactic acidosis 1976, Blackwell Scientific Publications, Boston.
30. Levy B., Sadoune L.O., Gelot A.M., et al. Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-treated septic shock. Crit Care Med 2000, 28:114-119.
31. Gilbert E.M., Haupt M.T., Mandanas R.Y., et al. The effect of liquid loading, blood transfusion, and catecholamine infusion on oxygen delivery and consumption in patients with sepsis. Am Rev Respir Dis 1986, 134:873-878.
32. Gore D.C., Jahoor F., Hibbert J.M., et al. Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Ann Surg 1996, 224:97-102.
33. Levy B. Lactate and shock state: the metabolic review. Curr Opin Crit Care 2006, 12:315-321.
34. Boeksteggers P., Weidenhofer S., Kapsner T., et al. Skeletal muscle partial pressure of oxygen in patients with sepsis. Crit Care Med 1994, 22:640-650.
35. Hotchkiss R.S., Karl I.E. Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA 1992, 267:1503-1510.
36. Stacpoole P.W., Harman E.M., Curry S.H., et al. Treatment of lactic acidosis with dichloroacetate. N Engl J Med 1983, 309:390-396.
37. De Baker D., Creteur J., Silva E., et al. The hepatosplanchnic area is not a common source of lactate in patients with severe sepsis. Crit Care Med 2001, 29:256-261.
38. Iscra F., Gullo A., Biolo G. Bench-to-bedside review: lactate and the lung. Crit Care 2002, 6:327-329.
39. Zeller W.P., The S.M., Sweet M., et al. Altered glucose transporter mRNA abundance in the rat model of endotoxemic shock. Biochem Biophys Res Commun 1991, 176:535-540.
40. Karimova A., Pinsky D.J. The endothelial response to oxygen deprivation: biology and clinical implications. Intensive Care Med 2001, 27:19-31.
41. Wheater P.R., Burkitt H.G., Daniels V.G., et al. Functional histology: a text and colour atlas 1979, Churchill Livingstone, New York.
42. Schurr A., Payne R.S., Miller J.J., et al. Brain lactate is an obligatory aerobic energy substrate for functional recovery after hypoxia: further in vitro validation. J Neurochem 1997, 69:423-426.
43. Kline J.A., Thronton L.R., Lopaschuk G.D., et al. Lactate improves cardiac efficiency after hemorrhagic shock. Shock 2000, 14:215-221.
44. Levraut J., Ciebiera J.P., Chasve S., et al. Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir Crit Care Med 1998, 157:1021-1026.
45. Revelly J.P., Tappy L., Martinez A., et al. Lactate and glucose metabolism in severe sepsis and septic shock. Crit Care Med 2005, 33:2235-2240.
46. Stacpoole P.W., Nagaraja N.V., Hutson A.D. Efficacy of dichloroacetate as a lactate-lowering drug. J Clin Pharmacol 2003, 43:683-691.
47. Guidot D.M., Folkesson H.G., Jain L., et al. Integrating acute lung injury and regulation of alveolar fluid clearance. Am J Physiol Lung Cell Mol Physiol 2006, 291:L301-L306.
48. Negash S., Narasimhan S.R., Zhou W., et al. Role of cGMP-dependent protein kinase in regulation of pulmonary vascular smooth muscle cell adhesion and migration: effect of hypoxia. Am J Physiol Heart Circ Physiol 2009, 297(1):H304-H312.
49. Baboolal H.A., Ichinose F., Ullrich R., et al. Reactive oxygen species scavengers attenuate endotoxin-induced impairment of hypoxic pulmonary vasoconstriction in mice. Anesthesiology 2002, 97(5):1227-1233.
50. Liang W., Ray J.B., He J.Z., et al. Regulation of proliferation and membrane potential by chloride currents in rat pulmonary artery smooth muscle cells. Hypertension 2009, 54:286-293.
51. Struck J., Uhlein M., Mortgenthaler N.G., et al. Release of mitochondrial enzyme carbamoyl phosphate synthase under septic conditions. Shock 2005, 23:533-538.
52. Crouser E.D., Julian M.W., Huff J.E., et al. Carbamoyl phosphate synthase-1: a marker of mitochondrial damage and depletion in the liver during sepsis. Crit Care Med 2006, 34(9):2439-2446.
53. Sykes E., Cosgrove J.F. Acute renal failure and the critically ill surgical patient. Ann R Coll Surg Engl 2007, 89(1):22-29.
54. Rosenberger C., Rosen S., Heyman S.N. Renal parenchymal oxygenation and hypoxia adaptation in acute kidney injury. Clin Exp Pharmacol Physiol 2006, 33:980-988.
55. Tillyard A., Keays R., Soni N. The diagnosis of acute renal failure in intensive care: mongrel or pedigree?. Anaesthesia 2005, 60:903-914.
56. Jobsis F.F. Noninvasive, infrared monitoring of cerebral oxygen sufficiency and circulation parameters. Science 1977, 198(4323):1264-1267.
57. Mancini D.M., Bolinger L., Li H., et al. Validation of near-infrared spectroscopy in humans. J Appl Physiol 1994, 776:2740-2747.
58. Colier WNJM. Near-infrared spectroscopy: toy or tool? An investigation on the clinical applicability of near-infrared spectroscopy. Thesis, University of Nijmegen. The Netherlands; 1995. p. 9-106.
59. Cairns C.B., Moore F.A., Haenel J.B., et al. Evidence for early supply independent mitochondrial dysfunction in patients developing multiple organ failure after trauma. J Trauma 1997, 423:532-536.
60. McKinley B.A., Marvin R.G., Cocanour C.S., et al. Tissue hemoglobin O2 saturation during resuscitation of traumatic shock monitored using near-infrared spectrometry. J Trauma 2000, 48:637-642.
61. Ince C., Sinaasappel M. Microcirculatory oxygen and shunting in sepsis and shock. Crit Care Med 1999, 27:1369-1377.
62. Nahum E., Skippen P.W., Gagnon R.E. Correlation of transhepatic near-infrared spectroscopy readings with liver surface readings and perfusion parameters in a piglet endotoxemic shock model. Liver Int 2006, 26(10):1277-1282.
63. Mesquida J., Masip J., Gili G., et al. Thenar oxygen saturation measured by near-infrared spectroscopy as a noninvasive predictor of low central venous oxygenation in septic patients. Intensive Care Med 2009, 35(6):1106-1109.
64. Poeze M. Tissue-oxygenation assessment using near-infrared spectroscopy during severe sepsis: confounding effects of tissue edema on StO2 values. Intensive Care Med 2006, 32:788-789.
65. Fredrich O. Critical illness myopathy: sepsis-mediated failure of the peripheral nervous system. Eur J Anaesthesiol Suppl 2008, 42:73-82.